Antigen-antibody complex as therapeutic vaccine for viral hepatitis B
- PMID: 10614727
- DOI: 10.3109/08830189909043028
Antigen-antibody complex as therapeutic vaccine for viral hepatitis B
Abstract
In a previous study, hepatitis B surface antigen (HBsAg) complexed to human anti-HBs immunoglobulins (HBIG) in excess of HBsAg was used as therapeutic vaccine to treat chronic hepatitis B patients and promising results were obtained. To study the mechanisms of this approach, mice were immunized with HBsAg or IC (immunogenic complex, i.e. HBsAg complexed with mouse polyclonal anti-HBs). Studies indicate that IC induced enhanced immune responses by increasing uptake of HBsAg through Fc receptors on antigen presenting cells and modulated HBsAg processing and presentation. This modulation led to stimulation of T cell responses, and increased production of IL-2 and IFN-gamma. Assay for antibody subclasses showed that higher ratio of IgG 2a was observed in the IC immunized group, which correlated with the production of lymphokine pattern. When alum was used as the adjuvant, though antibody response was enhanced, production of cytokines decreased. When DNA from a recombinant plasmid was added to IC as an adjuvant, the titer of anti-HBs was significantly higher than those in mice immunized only with the DNA or the IC. Since DNA immunization can induce both cellular and humoral immune responses, combined immunization using IC and DNA might serve as another type of therapeutic vaccine for viral hepatitis B.
Similar articles
-
[Advances on antigen-antibody immunogenic complex therapeutic vaccine for viral hepatitis B].Zhonghua Gan Zang Bing Za Zhi. 2009 Sep;17(9):718-20. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19785971 Review. Chinese. No abstract available.
-
Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice.Vaccine. 2001 Jul 20;19(30):4219-25. doi: 10.1016/s0264-410x(01)00158-x. Vaccine. 2001. PMID: 11457548
-
Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.Vaccine. 2015 Aug 20;33(35):4247-54. doi: 10.1016/j.vaccine.2015.03.079. Epub 2015 Apr 6. Vaccine. 2015. PMID: 25858855
-
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.J Hepatol. 2013 Sep;59(3):450-6. doi: 10.1016/j.jhep.2013.05.003. Epub 2013 May 11. J Hepatol. 2013. PMID: 23669281 Clinical Trial.
-
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.Ann N Y Acad Sci. 1995 Nov 27;772:64-76. doi: 10.1111/j.1749-6632.1995.tb44732.x. Ann N Y Acad Sci. 1995. PMID: 8546414 Review.
Cited by
-
Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.Emerg Microbes Infect. 2016 Aug 17;5(8):e92. doi: 10.1038/emi.2016.97. Emerg Microbes Infect. 2016. PMID: 27530750 Free PMC article. Review.
-
A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population.World J Gastroenterol. 2011 Aug 21;17(31):3640-4. doi: 10.3748/wjg.v17.i31.3640. World J Gastroenterol. 2011. PMID: 21987612 Free PMC article.
-
Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.Infect Immun. 2004 Aug;72(8):4680-8. doi: 10.1128/IAI.72.8.4680-4688.2004. Infect Immun. 2004. PMID: 15271929 Free PMC article.
-
Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.World J Gastroenterol. 2003 Jul;9(7):1512-5. doi: 10.3748/wjg.v9.i7.1512. World J Gastroenterol. 2003. PMID: 12854153 Free PMC article.
-
Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques.J Virol. 2003 Jan;77(1):10-24. doi: 10.1128/jvi.77.1.10-24.2003. J Virol. 2003. PMID: 12477806 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources